Introduction {#s1}
============

Pyrethroids are synthetic insecticides that structurally mimic pyrethrins derived from the flower of *Chrysanthemum* sp. ([@c16]). Pyrethroids account for approximately 25% of the insecticidal market worldwide with increasing usage due to the ban of organophosphates for home use in many countries, including the United States ([@c1]; [@c35]). The extensive use of pyrethroids for domestic, industrial, and agricultural settings increases the potential of exposure through multiple routes, especially to susceptible populations, including children and pregnant women ([@c74]). Pyrethroids are heuristically divided into two major groups according to their structural properties and acute intoxication syndromes. Type I pyrethroids lacking a cyano moiety at the $\alpha$ carbon of the 3-phenoxybenzyl alcohol moiety produce tremor syndrome, including hyperexcitation, tremors, and convulsions, whereas Type II pyrethroids possessing an $\alpha –\text{cyano}$ group induce choreoathetosis and salivation syndrome, characterized as hypersensitivity, choreoathetosis, salivation, and seizures ([@c85]; [@c97]). A few pyrethroids produce mixed signs, including both tremors and salivation, and are classified as Type I/II ([@c85]; [@c97]).

Pyrethroids have been demonstrated to interact with several types of ion channels, including voltage-gated calcium channels ([@c55]; [@c56]), two-pore domain potassium channels ([@c17]), and voltage-dependent chloride channels ([@c31]; [@c89]). Historically, the acute neurotoxicity of pyrethroids have been attributed to their ability to selectively bind to axonal voltage-gated sodium channels (VGSCs) ([@c12]; [@c20]; [@c84]). Pyrethroids delay inactivation kinetics of VGSCs, resulting in altered patterns of neuronal excitability manifested both *in vitro* and *in vivo* by increased neuronal firing rates with epochs of repetitive discharges or depolarizing block of neurotransmission ([@c20]; [@c63]; [@c84]; [@c92]). However, a consistent observation across studies indicates that concentrations $> 10\;\mu M$ are necessary to elicit changes in mammalian VGSC function for many pyrethroids ([@c20]; [@c30]).

Pyrethroids or the major pyrethroid metabolites, 3-phenoxybenzoic acid (3-PBA), *cis*-3-(2,2-dichlorovinyl)-2,2-dimethyl-(1-cyclopropane) carboxylic acid (*cis*-DCCA), and *trans*-3-(2,2-dichlorovinyl)-2,2-dimethyl-(1-cyclopropane) carboxylic acid (*trans*-DCCA) have been detected in most environmental samples collected from homes ([@c59]; [@c70]; [@c99]) and child care facilities ([@c59]), as well as urinary samples collected from mothers ([@c23]; [@c70]) and children ([@c23]; [@c70]; [@c99]). Exposures varied with geographic location as listed in [Table 1](#t1){ref-type="table"} and were correlated to patterns of pyrethroid use ([@c59]; [@c65]; [@c99]). The total level of three pyrethroid metabolites could reach as high as $262\text{ \ ng}/{mL}$ ([@c99]). In addition to the urinary samples, human breast milk also contained pyrethroids whose levels varied widely ([@c21]; [@c78]), a consequence likely resulting from differential exposures. Thus, pyrethroid exposure during the perinatal and early childhood periods may contribute to increased risks for neurotoxicity. Results from two recent studies based on residential proximity to agricultural pesticides in California suggested an association between prenatal exposure to pyrethroids and increased risks for attention-deficit/hyperactivity disorder (ADHD) ([@c80]) and delayed perceptual reasoning and verbal comprehension scores ([@c39]). Results from a study of pyrethroid exposure during pregnancy in China identified associations between pyrethroid metabolites in maternal urine with adverse outcomes on the growth and development of infants ([@c101]). Although a high concentration of 3-PBA has been detected in urinary samples, 3-PBA did not affect the viability of SH-SY5Y cells at concentrations as high as $100\;\mu M$ ([@c73]).

###### 

Concentrations of urinary pyrethroid metabolites in different populations.

Table 1 has 4 columns. The first column lists metabolites by sample source. The adjacent columns list median and maximal concentration for exposure levels (micrograms per liter) and references.

  Metabolites by sample source               Exposure levels ($\mu g/L$)   References   
  ------------------------------------------ ----------------------------- ------------ -----------
  Children at 6--11 y of age (Canada)        ---                           ---          ([@c65])
   3-PBA                                     0.2                           32           ---
   *cis*-DBCA                                $< 0.006$                     2            ---
   *cis*-DCCA                                0.05                          6            ---
   *trans*-DCCA                              0.15                          41           ---
  Infants at 12 months of age (China)        ---                           ---          ([@c99])
   3*-*PBA                                   0.39                          90.26        ---
   *cis-*DCCA                                0.18                          6.82         ---
   *trans-*DCCA                              0.92                          236.28       ---
  Pregnant women (China)                     ---                           ---          ([@c101])
   3-PBA                                     2.24                          52.13        ---
   *cis-*DCCA                                1.22                          80.19        ---
   *trans-*DCCA                              3.65                          85.26        ---
  Preschool children (Ohio, United States)   ---                           ---          ([@c59])
   3-PBA                                     0.3                           33.3         ---

Note: ---, no data; *cis*-DBCA, *cis*-(2,2-dibromovinyl)-2,2-dimethylcyclopropane-1-carboxylic acid; *cis*-DCCA, *cis-*(2,2-dichlorovinyl)-2,2-dimethylcyclopropane-1-carboxylic acid; *trans*-DCCA, *trans-*(2,2-dichlorovinyl)-2,2-dimethylcyclopropane-1-carboxylic acid; 3-PBA, 3-phenoxybenzoic acid.

Mice exposed prenatally to low doses ($0.3\;{mg}/{kg}$ and $1\;{mg}/{kg}$) of deltamethrin (DM), a Type II pyrethroid, displayed ADHD-like behavior including hyperactivity, working memory and attention deficits, and impulsive-like behaviors that were presumably mediated by altered dopaminergic signal pathways ([@c72]). The concentration of DM in brain tissue has been shown to reach $\sim 16\text{ \ ng}/g$ ($30\text{ \ nM}$) after a single oral dose of $0.5\;{mg}/{kg}$ DM in postnatal day 21 rats ([@c61]).

Primary cortical neurons exhibit spontaneous electrical discharges consisting of infrequent synchronized as well as desynchronized randomized field potentials as they formed functional neuronal networks ([@c9]; [@c33]). Developing neuronal networks also display spontaneous synchronized ${Ca}^{2 +}$ oscillations (SCOs) ([@c10]), whose patterns depend on the balance of excitatory and inhibitory neurotransmission within the neuronal network ([@c66]). SCOs are orchestrated by multiple ${Ca}^{2 +}$ signaling pathways that are highly integrated and regulated ([@c26]). SCOs depend on electrical spike activity (ESA) ([@c86]), and both are crucial for neuronal development, activity-dependent neurite outgrowth, and network plasticity ([@c24]; [@c86]; [@c94]). During early development *in vitro*, dendritic arborization, axonal elongation, and synapse formation form extensive neuronal network at around 6 d *in vitro* (DIV) ([@c36]; [@c41]). Consistent with morphological development, electric spiking activity occurs as early as 3 DIV ([@c81]), whereas the synchrony of spike activity ([@c22]; [@c33]) as well as SCOs ([@c15]; [@c14]) manifest after 6 DIV and gradually increase and stabilize between 10--12 DIV, at which time they exhibit long-distance network connectivity. We previously demonstrated that at relatively high concentrations ($> 1\;\mu M$), DM triggered a long-lived elevation of cytosolic intracellular ${Ca}^{2 +}$ concentrations primarily mediated by enhanced influx of extracellular ${Ca}^{2 +}$ that occurred concomitantly with depolarization of the neuronal ([@c13]). This ${Ca}^{2 +}$ influx in primary cortical neurons cultured from rat was closely associated with changes in the expression of brain-derived neurotrophic factor (*Bdnf*) ([@c45], [@c44]). However, a lower concentration of DM ($0.3\;\mu M$) decreased the SCO amplitude without detectable changes in the baseline intracellular ${Ca}^{2 +}$ concentration ([@c13]). Ryanodine receptors (RyRs), together with inositol-1,4,5-trisphosphate receptors ($\text{IP}_{3}R$) influence ${Ca}^{2 +}$ release from sarcoplasmic reticulum/endoplasmic reticulum (SR/ER) stores, and thus mediate a myriad of ${Ca}^{2 +}\text{-regulated}$ cellular processes ([@c53]; [@c68]). Initial screening showed that DM at $5\;\mu M$ increased $$ ($$) binding to membrane vesicles, suggesting its direct activation of RyRs ([@c60]), an intracellular ${Ca}^{2 +}$ channel localized to the endoplasmic reticulum crucial for regulating ${Ca}^{2 +}$ dynamics and activity-dependent dendritic growth ([@c93], [@c95]). Although it has become clear that DM may alter ${Ca}^{2 +}$ dynamics in neurons, more information is needed to understand the impact on hallmarks of neuronal morphology and electric activity at concentrations more relevant to current human tissue levels (nanomolar concentration) and to clarify the potential mechanisms, especially those targeting RyRs.

We posited that environmental relevant level of DM could alter the morphological complexity and patterns of network activity within primary cultured cortical neurons that were mediated by altered activities of RyR channels within the same concentration range. Here we provide, to our knowledge, the first detailed investigation of how nanomolar DM influenced ${Ca}^{2 +}$ dynamics, ESA, and morphological complexity in cortical neurons cultured from wild-type (WT) and $\text{RyR}1^{T4826I/T4826I}$ mice. Considering their implication in neurotoxicity, we directly investigated how nanomolar DM influenced gating kinetics of RyRs. Our new findings are likely relevant for understanding the biological plausibility and molecular mechanisms mediating abnormal neuronal network formation and function-associated DM exposures.

Materials and Methods {#s2}
=====================

Animals and Reagents {#s2.1}
--------------------

Male and female WT C57BL/6J mice purchased from the Jackson Laboratory and $\text{RyR}1^{T4826I/T4826I}$ knock-in C57BL/6J mice established as previous described ([@c2]; [@c102]) were housed in the animal facility of School of Veterinary Medicine in the University of California, Davis (UC Davis), under specific pathogen-free conditions, at a controlled temperature of $22 \pm 2{^\circ}C$ and humidity of $50 \pm 10\%$, with a cycle of 12 h light and 12 h dark. Animals were provided with Mouse Diet 20 (PicoLab) and autoclaved drinking water provided by UC Davis animal facility *ad libitum*. Well-trained, certified staff were responsible for the periodic breeding work to provide neonatal mice for primary cultures. All the animal related procedures met the requirements of the guidelines of Animal Use and Care of the National Institutes of Health and approved by the UC Davis Animal Use and Care Committee. The reagents used in this study are summarized in Table S1.

Primary Cortical Neurons Cultured from Neonatal Mice {#s2.2}
----------------------------------------------------

Primary cultured neurons were used as a model reported to develop morphological ([@c15]) as well as functional changes that recapitulate several hallmarks of neurodevelopment observed *in vivo* ([@c27]; [@c87]). Procedures culturing cortical neurons from postnatal day 0 or 1 (both male and female) C57BL/6J WT and $\text{RyR}1^{T4826I/T4826I}$ knock-in mice were performed as described previously ([@c13]). In brief, the dissociated cells were suspended in prewarmed neurobasal complete (NBC) medium \[neurobasal medium supplemented with GS21 (2%, v/v), GlutaMAX (1%, v/v), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES; $10\text{ \ mM}$)\] containing 5% fetal bovine serum (FBS). Suspended cells were plated onto poly L-lysine ($0.5\;{mg}/{mL}$ in borate buffer) precoated 96-well imaging plate (BD Biosciences) at densities of 2,000; 75,000; and 130,000 cells/well for axonal and dendritic outgrowth, SCO, and microelectrode array (MEA) measurements, respectively. A final concentration of $5\;\mu M$ of cytosine $\beta\text{-}D\text{-\ arabinofuranoside}$ dissolved in FBS-free NBC was added at 24--30 h after plating. The neurons were maintained at 37°C with 5% ${CO}_{2}$ and 95% humidity until use at specified DIV.

Measurements of Intracellular Synchronous ${Ca}^{2 +}$ Oscillations {#s2.3}
-------------------------------------------------------------------

Intracellular ${Ca}^{2 +}$ dynamics in cultured neurons were measured as previously described ([@c15]). In brief, after incubation with the ${Ca}^{2 +}$ indicator Fluo-4/AM ($4\;\mu M$) for 1 h, neurons were gently rinsed with prewarmed Locke's buffer (in mM: HEPES 8.6, KCl 5.6, NaCl 154, D-glucose 5.6, ${MgCl}_{2}$ 1.0, ${CaCl}_{2}$ 2.3, and glycine 0.1, pH 7.4) four times with a final volume of $175\;\mu L$ per well. The plate was then loaded onto the imaging chamber of fluorescent imaging plate reader ($\text{FLIPR}^{\text{Tetra}}$, Molecular Devices). After an equilibration period of 5 min, SCO events were recorded for 120 s followed by the addition of vehicle \[0.1% dimethylsulfoxide (DMSO)\] or a defined concentration of DM ($25\;\mu L$, $8 \times$ final concentration) using an automated, programmable pipetting system, and the fluorescent signals (F) were recorded for an additional 1,500 s at a sampling rate of $1\text{ \ Hz}$. To measure the susceptibility to DM of cortical neurons at distinct development stages of *in vitro* cultures, the same batch neurons cultured in 96-well sister plates on 6, 8, 10, and 12 DIVs were used. To measure the developmental pattern of SCO in cortical neurons culture *in vitro*, ${Ca}^{2 +}$ dynamics were recorded for 600 s after an equilibration period of 5 min. The recordings were from the same batch of neurons cultured in 96-well sister plates on 2, 4, 6, 8, 10, and 12 DIVs. Half volume of the medium was changed with NBC at 4, 6, 8, 10, and 12 DIVs after recording the SCOs in the sister plates. For the subchronic exposure study, the cells were continuously treated with different concentrations of DM at 3 h postplating, and SCOs were recorded at 7 DIV. To compare the influence of RyR1 on SCO patterns and DM inhibition on SCO frequency and amplitude in both genotypes, paired cultures in the same 96-well imaging plate from WT and $\text{RyR}1^{T4826I/T4826I}$ pups were recorded simultaneously at 7 DIV. Data were presented as $\Delta F/F_{0}$, where $F_{0}$ is the minimal arbitrary fluorescence unit before addition. An event with amplitude $\left( \Delta F/F_{0} \right) > 0.15$ was considered to be an SCO. Peak amplitude and frequency were analyzed using Origin software (version 9.0; Origin Lab Corporation). SCO events recorded between 5 and 25 min after additions of test compound were analyzed to quantify DM effect on SCOs, since addition of fluid had an artificial disturbance on SCO pattern in the initial several minutes. Each experiment was repeated in at least three independent cultures. The averaged SCO frequency and amplitude from a culture were used as data points. The concentration--response curves of DM SCO response were fitted with a nonlinear logistic equation using Prism GraphPad software (version 7.0; GraphPad Software). One-way analysis of variance (ANOVA) followed by post hoc Bonferroni comparison were used to compare the statistical significance of SCO frequency and amplitude between different DIVs. *t*-Test was used to compare the statistical significance of SCO frequency and amplitude between WT and $\text{RyR}1^{T4826I/T4826I}$ neurons as well as the DM inhibition (percentage control of respective genotype) on SCO frequency and amplitude between two genotypes.

Measurements of Neuronal Electrical Spike Activity {#s2.4}
--------------------------------------------------

Network ESA were recorded using 12-well MEA Maestro plates (Axion BioSystems) at 37°C as described previously ([@c11]). MEA recording is an intact measurement that permits one to determine the ESA in the same population of neurons at different stages. Briefly, the 12-well Maestro plates with cortical neuron cultures at 5, 8, 11, and 14 DIVs were loaded onto a temperature-regulated head stage connected to a recording amplifier, and electric signals were acquired using AxIS software (Version 2.4, Axion BioSystems) for 15 min after an equilibration period of 5 min. Signals were acquired at a sampling frequency of $12.5\text{ \ kHz}$ and filtered using Butterworth Band-Pass filter (cutoff frequency of $200\text{ \ Hz}–3\text{ \ kHz}$). The AxIS software was used to detect spontaneous events with a threshold of $\geq 8$ times of the noise amplitude. NeuroExplorer software (version 4.0; NEX Technologies) was used to generate representative raster plot and the parameters such as number of active electrodes, spike frequency, burst frequency, and network burst frequency. DM exposure was initiated at 3 h postplating, and half-medium changes were conducted at 6, 9, and 12 DIVs with NBC containing the same concentrations of DM. Each experiment was repeated in at least three independent cultures, with four replicates per culture. The raw data of network activity was presented to reflect the developmental changes, and the DM responses in network activity in 5, 8, 11, and 14 DIVs were normalized to vehicle control (0.1% DMSO) obtained in respective DIVs. The averaged values of ESA parameters (spike frequency, burst frequency, and network burst frequency) from a culture were used as data points. Repeated measurements one-way ANOVA followed by post hoc Bonferroni comparison were used to compare the statistical significance of the ESA between two consecutive development DIVs. Ordinary two-way ANOVA followed by post hoc Bonferroni multiple comparison were used to determine the statistical significance between vehicle and DM-treated groups.

Immunocytochemistry and Morphometric Analysis {#s2.5}
---------------------------------------------

Immunocytochemistry was performed to visualize the morphology of neurons as previously described ([@c18]). The genesis of axonal growth has been demonstrated by 1 DIV and dendritic arbor formation manifests by 5 DIV ([@c6]; [@c25]). Cortical neurons cultured in 96-well imaging plates were exposed to defined concentration ($3\text{ \ nM}–1,000\text{ \ nM}$) of DM from 3 h after plating. The neurons were fixed with 4% paraformaldehyde for 10 min at 2 and 7 DIVs for axonal growth and dendritic complexity analysis, respectively. After washing with PBS ($4 \times 5\text{ \ min}$ each), the cells were permeabilized with 0.25% Triton X-100 for 5 min followed by blocking with 10% goat serum for 1 h. After washing with PBS ($4 \times 5\text{ \ min}$ each), cells were then incubated with anti-MAP-2B primary antibody (1:2000) in PBS containing 10% goat serum overnight at 4°C. Cells were washed with PBS ($4 \times 5\text{ \ min}$ each) and then incubated with Alexa Fluor^®^ 488--conjugated goat anti-chicken secondary antibody (1:500) for 1 h at room temperature. Pictures were recorded using an ImageXpress^®^ High Content Imaging System (Molecular Devices) using a $10 \times \text{objective}$ with fluorescein isothiocyanate filter. The ImageXpress^®^ High Content Imaging System was able to compartmentalize each well to different zones and capture the pictures in each zone by imputing the parameters of a 96-well plate. Nine adjacent sites ($3 \times 3$), which cover $\sim 60\%$ of the center surface area, were pictured for each well. The longest neurite that exceeded three times the length of the cell body (soma) was counted as an axon. Images digitized at 8-bit were used to manually trace axons and length using Image J software (version 1.49s; U.S. National Institutes of Health) with Neuron J Plugin as previously described ([@c57]). An axon was continuously traced from the edge of the cell body until the fluorescence signal/background noise ratio was $< 1.2$. Image J software was used for Sholl analysis ([@c29]) with rings set at 5-pixel increments from the soma ($1\text{ \ pixel} = 0.65\;\mu m$). In brief, after exporting the image to Image J, the center of individual neurons was defined, and the numbers of intersections at each ring with different distance to soma were counted using a macro, as described previously ([@c90]). Each experiment was repeated on at least two independent cultures, with at least three wells in each culture. Axonal length and mean value of intersections of each neuron were used to determine the $n$ value, as described in previous papers ([@c49]; [@c62]). One-way ANOVA followed by post hoc Bonferroni comparison was used to compare the statistical significance between vehicle- and DM-exposed groups. To assess the influence of sample size in the analysis, a randomly subsampling strategy was used. Specifically, an equal number of samples were randomly chosen from each group for 100 times, and the ANOVA test with Bonferroni correction was performed at each subset using R package software (version 3.4.1; R Development Core Team). Statistical significance between WT and $\text{RyR}1^{T4826I/T4826I}$ neurons and DM response was performed using two-way ANOVA.

Preparation of RyR1 and RyR2 from Muscle and Mixed RyRs from Brain {#s2.6}
------------------------------------------------------------------

A junctional SR membrane fraction enriched in RyR1 was isolated from fast-twitch skeletal muscles of $< 1\text{-}y\text{-\ old\ male}$ ($\sim 3\;{kg}$) New Zealand White rabbits (Charles River Laboratories), as previously described ([@c69]; [@c75]). Briefly, ground skeletal muscle was homogenized, and membrane fractions were separated with differential centrifugation to obtain a crude membrane fraction that was further purified by sucrose-density gradient centrifugation overnight to harvest the junctional sarcoplasmic reticulum membrane fraction enriched in RyR1. The fractions between 38--45% sucrose layers were collected, pooled, spin-down, resuspended, and stored at $- 80{^\circ}C$ until use. A cardiac microsomal preparation enriched in RyR2 and a brain cortical homogenate containing a mixture of all three isoforms of RyR1, RyR2, and RyR3 ([@c3]) were prepared from WT C57BL/6J mice (3--6 months old), as described previously ([@c3]; [@c28]; [@c98]; [@c104]). To obtain microsomal homogenates, ground cardiac tissue was suspended and subjected to two sequential bursts of 30 s each at $23,000\text{ \ rpm}$ using a PowerGen 700D (Fisher Scientific); ground brain cortical tissue was suspended and homogenized using a Potter-Elvehjem tissue grinder (VWR) for 30 s, repeated three times, in a 30-s interval between two homogenizations. Homogenates were then centrifuged at $1,000\text{ \ rpm}$ for 30 s, and the supernatant was collected and further centrifuged $110,000 \times g$ for 1 h at 4°C. The pellets were collected and resuspended, and stored at $–80\,{^\circ}C$. Protein concentrations were determined using the DC™ protein assay kit.

Equilibrium $$ Binding Analysis {#s2.7}
-------------------------------

Equilibrium binding analyses of $$ to skeletal muscle RyR1 ($0.05\;{mg}/{mL}$), cardiac muscle RyR2 ($0.5\;{mg}/{mL}$), and brain cortical homogenates ($0.5\;{mg}/{mL}$) were measured at 37°C for 3 h with constantly shaking in a binding buffer consisting of $250\text{ \ mM}$ KCl, $14\text{ \ mM}$ NaCl, $20\text{ \ mM}$ HEPES, pH 7.4, and $2\;\mu M$ free ${Ca}^{2 +}$ (obtained by the addition of egtazic acid calculated using the software bound and determined ([@c5]). The concentrations of $$ (specific activity: $56.6\text{ \ Ci}/\text{mmol}$; PerkinElmer) were used at $1\text{ \ nM}$, $2\text{ \ nM}$, and $10\text{ \ nM}$ for skeletal, cardiac, and brain preparations, respectively. Nonspecific $$ binding was measured in the presence of a 1,000-fold of unlabeled ryanodine. Samples were harvested by rapid filtration through Whatman GF/B glass fiber filters (Whatman) using a 48-sample cell harvester (Brandel) to wash three times with $5\;{mL}$ of ice-cold buffer containing (in mM) 250 KCl, 14 NaCl, 20 HEPES, and $2\;\mu M$ ${Ca}^{2 +}$, pH 7.4. $$ remained on filters was quantified using a Beckman scintillation counter (Model LS6500, Beckman). Experiments were repeated in three independent preparations with three replicates each, and the data was presented as $\text{mean} \pm \text{standard\ error\ of\ the\ mean\  }\left( \text{SEM} \right)$. The DM concentration--response curves were fitted with a nonlinear logistic equation using Prism GraphPad software.

Single-Channel Voltage Clamp {#s2.8}
----------------------------

Bilayer lipid membranes (BLM) were formed by mixing of $30\;{mg}/{mL}$ phosphatidylethanolamine, phosphatidylserine, and phosphatidylcholine in $n$-decane. RyR1 channel incorporation into BLM was accomplished by induced vesicle fusions with BLM, as previously described ([@c42]). The recording buffer used was $500\text{ \ mM}$ (*cis*-cytoplasmic side*)* and $50\text{ \ mM}$ *(trans*-luminal side*)* CsCl, buffered with $20\text{ \ mM}$ HEPES, pH 7.4, to establish a 10:1 ${Cs}^{+}$ gradient. Fluctuations in channel current were recorded at a holding potential of $- 40\text{ \ mV}$ applied to the *trans* side. DMSO (0.1%) as vehicle control and DM was sequentially added to the *cis* to reach the final concentrations of 10 and $30\text{ \ nM}$. Baseline (control) was recorded for 1--1.5 min before the extended time course of 3--15 min in the presence of DM. Data acquisition was made using digitizer DD1440A (Molecular Devices), digitized at $10\text{ \ kHz}$ and filtered with $1\text{-\ kHz}$ low-pass filter (8-pole low-pass Bessel filter; Warner Instruments). Data analysis was performed using Clampfit 10.4 (Molecular Devices) for channel open probability ($P_{o}$), mean open time ($\tau_{o}$), and mean closed time ($\tau_{c}$). Statistical significance between groups was calculated by one-way ANOVA followed by post hoc Bonferroni comparison. The data were from three independent single-channel recordings, and the changes in $P_{o}$, $\tau_{o}$, and $\tau_{c}$ were normalized to their respective controls of each channel.

MTT Assay {#s2.9}
---------

Neocortical neurons cultured in 96-well plate at 7 DIV were used to measure the cell viability using 3-(4,5-dimethylthiazol-2-yl)-2,5-triphenyl tetrazolium bromide (MTT) assay, as described previously ([@c103]). Briefly, after washing with Locke's buffer, neurons were exposed to vehicle (0.1% DMSO) or Fluo-4/AM ($4\;\mu M$) in the Locke's buffer for 1.5 h. The Locke's buffer was replaced with Neuronbasal Complete medium and incubated in a ${CO}_{2}$ incubator for additional 24 h. After aspirating the medium, a volume of $100\;\mu L$ medium containing $0.5\;{mg}/{mL}$ MTT was added to each well and incubated for 10 min at 37°C. After discarding the medium, a volume of $150\;\mu L$ DMSO was added to each well. The absorbance was measured at $570\text{ \ nm}$ and $650\text{ \ nm}$ in a microplate reader (Tecan Group Ltd.) to measure the content of formazan generated in each well. The data were presented as $\text{mean} \pm \text{SEM}$. A *t*-test was used to analyze the statistical significance between Fluo-4/AM and vehicle groups.

Preparation of Cis-(2,2-Dibromovinyl)-2,2-Dimethylcyclopropane-1-Carboxylic Acid {#s2.10}
--------------------------------------------------------------------------------

A total of $20\;{mg}$ of DM was dissolved in $6\;{mL}$ of methanol and mixed with $400\;\mu L$ of 10% NaOH. The DM was hydrolyzed by incubating the mixture at room temperature for 2 h. The reaction products were subjected to reverse-phase high-performance liquid chromatography on an Xtimate® C18 column ($10 \times 250\;{mm}$; Welch Tech.) eluted with 72% of methanol with a flow rate of $2\;{mL}/\text{min}$ for purification. One of hydrolytic metabolites, *Cis*-(2,2-dibromovinyl)-2,2-dimethylcyclopropane-1-carboxylic acid (*cis*-DBCA) ($\text{Retention\ time},\, t_{\text{R}} = 22.5\text{ \ min}$) was purified, and the structure was confirmed by NMR.

Statistical Analyses {#s2.11}
--------------------

All data were expressed as $\text{mean} \pm \text{SEM}$ and graphed using Prism GraphPad software. Statistical analysis was performed with appropriate comparisons described in each "Methods" section with Prism GraphPad software. A $p < 0.05$ was considered to be statistically significant.

Results {#s3}
=======

Developmental Patterns of Synchronous ${Ca}^{2 +}$ Oscillations and Electrical Spike Activity {#s3.1}
---------------------------------------------------------------------------------------------

A recent study reported that Fluo-4/AM suppressed the ouabain-sensitive ${Na}^{+}–K^{+}$ adenosine triphosphate activity, leading to neuron death ([@c83]). We therefore first examined the viability of primary cultured cortical neurons after exposure to Fluo-4/AM. Fluo-4/AM ($4\;\mu M$) had no effect on the neuronal viability ($p = 0.97$) under our experimental conditions (see Figure S1). Cortical neurons harvested from mice pups at postnatal day 0 to 1 and grown on 96-well plates at a density of 75,000 cells/well displayed distinctive patterns of SCO activity during the developmental window investigated (2 to 12 DIVs) ([Figure 1A,B](#f1){ref-type="fig"}). SCO frequency significantly increased during *in vitro* development ($F = 21.16$; $\text{degrees\ of\ freedom\ (DF)} = 5$; $p < 0.0001$) ([Figure 1C](#f1){ref-type="fig"}). Specifically, there was insufficient synapse formation to drive detectable network SCO activity at 2 DIV. By 4 DIV, SCOs were apparent (mean frequency of $0.93 \pm 0.04\text{ \ SCOs}/\text{min}$) and continued to gradually increase between 4 and 12 DIV, reaching $3.6 \pm 0.21\text{ \ SCOs}/\text{min}$ by 12 DIV ([Figure 1C](#f1){ref-type="fig"}). SCO amplitude also significantly changed during *in vitro* development ($F = 5.94$; $\text{DF} = 5$; $p = 0.005$) ([Figure 1C](#f1){ref-type="fig"}). Neuronal networks displayed a temporal increase in ${Ca}^{2 +}$ transient amplitude between 4 DIV ($0.68 \pm 0.01$) and 6 DIV ($1.1 \pm 0.29$), which gradually declined at longer DIV ([Figure 1C](#f1){ref-type="fig"}).

![Developmental patterns of SCOs in primary cortical neurons. (A) Schematic diagram outlining the measurement of SCO development changes in cultured cortical neuronal networks. (B) Representative traces of SCOs recorded from primary cortical neuronal network at 2, 4, 6, 8, 10, and 12 DIVs. (C) Quantification of the SCO frequency and amplitude at different developmental stages. The mean value of each plate was used as analysis unit. Each data point represents the $\text{mean} \pm \text{standard\ error\ of\ the\ mean\  }\left( \text{SEM} \right)$ from three independent cultures. One-way analysis of variance (ANOVA) followed by post hoc Bonferroni comparison was used to compare the statistical significance of SCO frequency and amplitude between different DIVs. Note: DIV, days *in vitro*; SCO, synchronous ${Ca}^{2 +}$ oscillations. \*$p < 0.05$; \*\*$p < 0.01$ vs. 2 DIV; ^\#\#^$p < 0.01$ vs. 4 DIV; ^\$\$^$p < 0.01$ vs. 6 DIV; ^&^$p < 0.05$ vs. 8 DIV.](ehp-127-067003-g0001){#f1}

Cortical neurons grown on MEA exhibited spontaneous ESAs that increased between 5 and 14 DIV ([Figure 2](#f2){ref-type="fig"}). The number of electrodes recording ESAs ($F = 25.12$; $\text{DF} = 3$; $p = 0.03$), mean spike frequency ($F = 9.43$; $\text{DF} = 3$; $p = 0.01$), burst frequency ($F = 6.02$; $\text{DF} = 3$; $p = 0.02$), and network burst frequency ($F = 6.67$; $\text{DF} = 3$; $p = 0.02$) all significantly increased with *in vitro* development ([Figure 2C--F](#f2){ref-type="fig"}). At 5 DIV, $7.7 \pm 3.4\%$ electrodes displayed measurable spike discharges that gradually increased to $49.8 \pm 10.2\%$ at 14 DIV ([Figure 2C](#f2){ref-type="fig"}). The average spike frequency of active electrodes at 5 DIV was $2.51 \pm 1.19\text{ \ spikes}/s$, and at 14 DIV reached $246.10 \pm 80.56\text{ \ spikes}/s$ ([Figure 2D](#f2){ref-type="fig"}). Beginning at 8 DIV, clusters of ESA (termed bursts) were detected, and their number gradually increased with neuron development, from $0.79 \pm 0.32\text{ \ bursts}/s$ at 8 DIV to $9.30 \pm 3.53\text{ \ bursts}/s$ at 14 DIVs ([Figure 2E](#f2){ref-type="fig"}). Network burst frequency represented a measure of the synchronicity ([@c91]) of events detected across the electrode array. Network bursting events were detected beginning at 8 DIV and increased tenfold by 14 DIV ([Figure 2F](#f2){ref-type="fig"}).

![Developmental patterns of ESA in primary cortical neurons. (A) Graphical paradigm outlining the measurement of ESA development changes in cultured cortical neuronal networks. (B) Representative raster plots of ESA in the same neuronal cultures at 5, 8, 11, and 14 DIVs. (C--F) Quantification of the number of (C) active electrodes, (D) spike frequency, (E) burst frequency, and (F) network burst frequency in neuronal cultures at different DIVs. The mean value of each plate was used as the analysis unit. Each data point shown in (B--E) represents the $\text{mean} \pm \text{standard\ error\ of\ the\ mean\  }\left( \text{SEM} \right)$ from three independent cultures. Repeated measurements one-way analysis of variance (ANOVA) analysis was used to analyze the number of active electrodes, spike frequency, burst frequency, and burst frequency during *in vitro* development. No statistical significance was observed between two different DIVs when using post hoc Bonferroni comparison. Note: DIV, days *in vitro*; ESA, electrical spike activity.](ehp-127-067003-g0002){#f2}

Influence of Acute Nanomolar Deltamethrin Exposure on Synchronous ${Ca}^{2 +}$ Oscillation Patterns {#s3.2}
---------------------------------------------------------------------------------------------------

We next investigated the acute effects of nanomolar DM exposure at 6, 8, 10, and 12 DIVs to determine how it influenced ESA parameters described above over the development *in vitro*. DM exposure rapidly suppressed SCO amplitude and frequency in a concentration-dependent manner, and the degree was dependent on the stage of development of the neuronal network ([Figure 3](#f3){ref-type="fig"}). The half-maximal inhibitory concentration ($\text{IC}_{50}$) values for DM suppressing SCO amplitude quantified between 5 and 25 min after addition of DM were $37.6\text{ \ nM}$ \[95% confidence interval (CI): 22.5, 62.3\], $21.3\text{ \ nM}$ (95% CI: 13.6, 33.4), $29.8\text{ \ nM}$ (95% CI: 20.3, 43.5), and $78.1\text{ \ nM}$ (95% CI: 26.2, 222.2) at 6, 8, 10, and 12 DIVs, respectively ([Figure 3B](#f3){ref-type="fig"}, right panel; [Table 2](#t2){ref-type="table"}). The maximal suppression of SCO amplitude by DM was highly dependent on neuronal development stages *in vitro*. At 6 DIV, DM could completely suppress SCO activity, whereas incomplete suppression of SCO amplitude was observed as the neuronal networks developed ([Figure 3B](#f3){ref-type="fig"}, right panel; [Table 2](#t2){ref-type="table"}). The maximal suppression of SCO amplitude at 8, 10, and 12 DIVs were 88.2% (95% CI: 80.0, 97.2), 67.8% (95% CI: 61.9, 74.1), and 60.5% (95% CI: 43.8, 85.5), respectively. DM also decreased SCO frequency at 6 and 8 DIVs \[$\text{IC}_{50}$ $139.6\text{ \ nM}$ (95% CI: 73.0, 262.9) and $190.8\text{ \ nM}$ (95% CI: 126.4, 1,471.0), respectively\]. At 10 and 12 DIVs, the maximal inhibition achieved at $1\;\mu M$ DM was only $29.5 \pm 3.7\%$ and $13.6 \pm 10.4\%$, respectively ([Figure 3B](#f3){ref-type="fig"}, left panel; [Table 2](#t2){ref-type="table"}). By comparison, the two major DM hydrolytic metabolites, 3-PBA and *cis*-DBCA, altered neither SCO frequency nor amplitude in 8 DIV cortical neurons ($F = 0.13$; $\text{DF} = 6$; $p = 0.99$) (Figure S2). This was consistent with the previous demonstration that 3-PBA did not affect the viability of SH-SY5Y cells, even at $100\;\mu M$ ([@c73]).

![Acute effect of DM on SCO patterns at specified DIVs. (A) Representative traces of SCOs measured at 6, 8, 10, and 12 DIVs neurons cultured in 96-well sister plates. Arrowhead together with the dashed line at 120 s indicate the addition of Veh (0.1% DMSO) or different concentrations of DM. Two additional dashed lines indicate the time frame that was used to quantify the SCO frequency and amplitude. (B) Concentration--response relationship for DM-altered SCO frequency (left panel) and SCO amplitude (right panel). The mean value of SCO frequency and amplitude from each plate was used as analysis unit. Each data point represents the $\text{mean} \pm \text{standard\ error\ of\ the\ mean\  }\left( \text{SEM} \right)$ from four independent cultures. The concentration--response curves of DM SCO response were fitted with a nonlinear logistic equation using Prism GraphPad software. The half-maximal inhibitory concentration ($\text{IC}_{50}$) values and maximal inhibition of DM at distinct DIVs are summarized in [Table 2](#t2){ref-type="table"}. Note: DIV, days *in vitro*; DM, deltamethrin; DMSO, dimethylsulfoxide; SCO, synchronous ${Ca}^{2 +}$ oscillations.](ehp-127-067003-g0003){#f3}

###### 

Relative potency and maximum inhibition of acute DM exposure on SCO parameters at different DIVs.

Table 2 has 5 columns. The first column lists DIVs. The adjacent columns list I C sub 50 and maximum inhibition percentage for SCO frequency and SCO amplitude.

  DIVs   SCO frequency            SCO amplitude                                                            
  ------ ------------------------ --------------------------------------------------- -------------------- ---------------------
  6      139.6 (73.0, 262.9)      100.0 (82.9, 124.7)                                 37.6 (22.5, 62.3)    100.0 (88.6, 112.7)
  8      190.8 (126.4; 1,471.0)   90.9 (73.6, 206.8)                                  21.3 (13.6, 33.4)    88.2 (80.0, 97.2)
  10     N.D.                     $29.5 \pm 3.7$[^*a*^](#TF3){ref-type="table-fn"}    29.8 (20.3, 43.5)    67.8 (61.9, 74.1)
  12     N.D.                     $13.6 \pm 10.4$[^*a*^](#TF3){ref-type="table-fn"}   78.1 (26.2, 222.2)   60.5 (43.8, 85.5)

Note: The half-maximal inhibitory concentration ($\text{IC}_{50}$) values and maximum inhibition were obtained by fitting the data in [Figure 3B](#f3){ref-type="fig"} with a nonlinear logistic equation using Prism GraphPad software. CI, confidence interval; DIV, days *in vitro*; DM, deltamethrin; Max. inhib., maximal inhibition; SCO, spontaneous ${Ca}^{2 +}$ oscillations; N.D., not determined.

Since the data obtained from 10 and 12 DIV did not permit curve fitting, the maximal inhibition was reported at $1\;\mu M$ DM.

Influences of Subchronic Deltamethrin Exposure on Network Synchronous ${Ca}^{2 +}$ Oscillation and Electrical Spike Activity Patterns {#s3.3}
-------------------------------------------------------------------------------------------------------------------------------------

Cortical neurons were exposed to vehicle or defined concentrations of DM beginning 3 h after cell plating and SCO patterns were measured on 7 DIV with $\text{FLIPR}^{\text{Tetra}}$ (Molecular Devices). Subchronic exposure to DM decreased the SCO frequency on 7 DIV relative to vehicle control \[$\text{IC}_{50}$ of $61.1\text{ \ nM}$ (95% CI: 29.1, 130.4)\], although suppression was incomplete at the highest DM concentration tested ([Figure 4A,B](#f4){ref-type="fig"}). Unlike acute exposure to DM shown in [Figure 3](#f3){ref-type="fig"}, subchronic DM did not reduce SCO amplitude, but rather produced a negligible trend toward SCO augmentation that was not statistically significant ([Figure 4B](#f4){ref-type="fig"}).

![Influence of subchronic DM exposures on SCO patterns. (A) Representative traces of SCOs measured at 7 DIV. Neurons were continuously exposed to Veh (0.1% DMSO) or different concentrations of DM starting from 3 h after plating. (B) Concentration--response relationships for DM altered SCO frequency and amplitude. The mean value of each plate was used as analysis unit. Each data point represents the $\text{mean} \pm \text{standard\ error\ of\ the\ mean\  }\left( \text{SEM} \right)$ from three independent cultures. The concentration--response curves of DM SCO response on frequency and amplitude were fitted with a nonlinear logistic equation using Prism GraphPad software. Note: DIV, days *in vitro*; DM, deltamethrin; DMSO, dimethylsulfoxide; SCO, synchronous ${Ca}^{2 +}$ oscillations; Veh, vehicle.](ehp-127-067003-g0004){#f4}

Cortical neurons plated on MEA were exposed to DM (10 and $30\text{ \ nM}$) beginning 3 h postplating to assess influences on ESA patterns at specified DIVs ([Figure 5](#f5){ref-type="fig"}). DM exposure significantly affected both spike frequency ($F = 44.52$; $\text{DF} = 2$; $p < 0.0001$) and burst frequency ($F = 11.88$; $\text{DF} = 2$; $p = 0.0002$) but not network burst frequency ($F = 0.20$; $\text{DF} = 2$; $p = 0.82$) ([Figure 5B--E](#f5){ref-type="fig"}). At 5 DIV, DM ($30\text{ \ nM}$) significantly reduced spike frequency and ESA burst by $62.5 \pm 10.1\%$ ($p < 0.01$), and $55.0 \pm 9.5\%$ ($p < 0.01$), respectively ([Figure 5B--D](#f5){ref-type="fig"}). These inhibitory effects of DM on spike frequency persisted through 14 DIV. However, the magnitude of DM-suppressed spike frequency declined as neuronal networks developed *in vitro* ([Figure 5C](#f5){ref-type="fig"}). By 14 DIV, subchronic DM exposure had no significant influence on burst frequency compared with control ([Figure 5D](#f5){ref-type="fig"}). Although we observed spike activity and burst firing as early as 5 DIV, network bursts occurred starting at 8 DIV ([Figure 5E](#f5){ref-type="fig"}). Subchronic exposure to DM (10 or $30\text{ \ nM}$) was without effect on the frequency of network bursts ([Figure 5E](#f5){ref-type="fig"}).

![Influence of subchronic DM exposures on patterns of ESA. (A) Graphical paradigm outlining subchronic DM exposure for ESA measurement. Neurons were continuously exposed to Veh (0.1% DMSO) or 10 or $30\text{ \ nM}$ DM commencing 3 h after plating, and ESA was recorded at 5, 8, 11, and 14 DIVs. (B) Representative raster plots of ESA recorded on cortical neurons at 5, 8, 11, and 14 DIVs. (C--E) Quantification of (C) spike frequency, (D) burst frequency, and (E) network burst frequency in the same neuronal cultures at different DIVs. The mean value of each plate was used as analysis unit. Each data point represents the $\text{mean} \pm \text{standard\ error\ of\ the\ mean\  }\left( \text{SEM} \right)$ from four independent cultures. Two-way analysis of variance (ANOVA) followed by post hoc Bonferroni multiple comparison was used to determine the statistical significance between Veh and DM-treated groups. Note: DIV, days *in vitro*; DM, deltamethrin; DMSO, dimethylsulfoxide; Veh, vehicle. \*$p < 0.05$; \*\*$p < 0.01$ vs. Veh at respective DIVs.](ehp-127-067003-g0005){#f5}

Influence of Deltamethrin on Axonal and Dendritic Outgrowth {#s3.4}
-----------------------------------------------------------

Considering the significant influences of DM on SCO and ESA patterns on neuronal networks *in vitro*, we posited that subchronic DM would influence morphometric properties of neuronal axonal growth and dendritic complexity. DM ($3–1,000\text{ \ nM}$) exposure, commencing 3 h after plating and continuing for 48 h and 7 d, was used to investigate the axon elongation and dendritic arborization, respectively. Vehicle (0.1% DMSO) treatment for 48 h had no effect on the axonal growth (Figure S3A,B). In contrast, DM exposure significantly affected axonal outgrowth ($\text{DF} = 6$; $F = 17.59$; $p < 0.0001$) and produced a nonmonotonic concentration--effect relationship on axonal elongation ([Figure 6](#f6){ref-type="fig"}). Cells treated with 10 and $30\text{ \ nM}$ DM had significantly longer axons (by $10.4 \pm 1.3\%$; $p < 0.01$; and $16.1 \pm 2.0\%$; $p < 0.01$, respectively) compared with vehicle-treated cells. The maximal axonal length was observed in the presence of $100\text{ \ nM}$ DM ($20.9 \pm 1.9\%$; $p < 0.01$) ([Figure 6C](#f6){ref-type="fig"}). Power analysis also showed the minimum sample sizes needed for detecting significant differences among treatment groups were 200, 130, and 300 neurons for 30, 100, and $300\text{ \ nM}$ DM, respectively (Figure S4). Vehicle (0.1% DMSO) treatment had no effect on neuron complexity (Figure S3C--E). However, neuronal cultures exposed DM ($100\text{ \ nM}$ and $300\text{ \ nM}$) under these conditions exhibited higher complexity that was dependent on the radius of the circles used in the Sholl analysis ([Figure 6D--E](#f6){ref-type="fig"}). DM significantly affected the number of intersections at radius of 30 pixels ($\text{DF} = 5$; $F = 6.12$; $p < 0.0001$) and 60 pixels ($\text{DF} = 5$; $F = 8.16$; $p < 0.0001$), respectively ([Figure 6F](#f6){ref-type="fig"}). At a radius of 30 pixels, the numbers of intersections were significantly higher by $13.3 \pm 1.7\%$ ($p < 0.05$) and $23.3 \pm 3.3\%$ ($p < 0.01$) in the presence of $100\text{ \ nM}$ and $300\text{ \ nM}$ of DM, respectively, compared with vehicle-treated cells. At a radius of 60 pixels, the number of intersections were significantly higher by $28.6 \pm 7.0\%$ ($p < 0.05$) and $30.1 \pm 10.1\%$ ($p < 0.05$), respectively ([Figure 6F](#f6){ref-type="fig"}). Lower concentrations of DM had no effect on dendritic complexity of cortical neurons under these experimental conditions ([Figure 6F](#f6){ref-type="fig"}).

![Subchronic effect of DM exposure on axonal and dendritic outgrowth. (A) Graphical paradigm outlining subchronic exposure of DM for axonal and dendritic outgrowth. (B) Representative images of neurons exposed to Veh (0.1% DMSO) and different concentrations of DM commencing 3 h after plating and immunostained with MAP-2B antibody at 2 DIV. (C) Quantification of the axon length in the absence and presence of DM exposure. (D) Image J--processed representative images of neuronal morphology immunostained with MAP-2B at 7 DIV. Neurons were continuously exposed to Veh (0.1% DMSO) or different concentrations of DM starting from 3 h after plating. (E) Quantification of numbers of intersections at different radius in the absence and presence of DM exposure. The number of intersections was plotted with different radius (pixels). (F) Quantification the dendritic complexity after DM exposure. The radii of 30 and 60 pixels were chosen to quantify the number of intersections. The total number of neurons tested was inserted in the bar graph, and axonal length and number of intersections of each neuron was used as analysis unit. Each data point represents the $\text{mean} \pm \text{standard\ error\ of\ the\ mean\  }\left( \text{SEM} \right)$ from three independent cultures. One-way analysis of variance (ANOVA) followed by post hoc Bonferroni comparison was used to compare the statistical significance between Veh and DM exposed groups. Arrowheads indicate the radii of 30 and 60 pixels, respectively. Note: DIV, days *in vitro*; DM, deltamethrin; DMSO, dimethylsulfoxide; Veh, vehicle. \*$p < 0.05$; \*\*$p < 0.01$ vs. Veh. $\text{Bar} = 50\;\mu m$.](ehp-127-067003-g0006){#f6}

Influence of Deltamethrin on Ryanodine Receptor Function {#s3.5}
--------------------------------------------------------

We further examined the mechanisms by which DM altered RyR function that was previously identified as a potential target of DM ([@c60]) using radioligand binding assay and single-channel lipid bilayer recording. Binding of $$ to RyR1 and RyR2 was higher at DM concentrations $> 3\;\mu M$ than with vehicle (Figure S5). In the skeletal muscle and cardiac muscle preparations, the maximal response reached 258.2% (95% CI: 240.4, 279.9) and 164.8% (95% CI: 147.7, 199.6) of respective vehicle (0.1% DMSO) controls (Table S2). Similarly, in the preparations derived from cortex, which expressed all three RyR isoforms ([@c28]), $$ binding was higher in the presence of DM, with a maximal increment of 239.5% (95% CI: 198.6, 294.8) of control (Figure S5; Table S2).

DM also altered the pattern of RyR1 single-channel gating kinetics in voltage clamp recordings ([Figure 7A--C](#f7){ref-type="fig"}). DM significantly affected mean closed time ($\text{DF} = 2$; $F = 166.3$; $p < 0.0001$), $\tau_{o}$, ($\text{DF} = 2$; $F = 147.0$; $p < 0.0001$), and open probability ($\text{DF} = 2$; $F = 24.77$; $p < 0.0025$) ([Figure 7D](#f7){ref-type="fig"}). DM at $10\text{ \ nM}$ and $30\text{ \ nM}$ significantly decreased the RyR1 channel $\tau_{c}$ to $25.1 \pm 10.1\%$ ($p < 0.01$) and $4.1 \pm 3.9\%$ ($p < 0.01$) of control ([Figure 7D](#f7){ref-type="fig"}). The $\tau_{o}$ was also significantly increased to $2.35 \pm 0.09$ folds ($p < 0.01$) of control after addition of DM ($30\text{ \ nM}$), while $10\text{ \ nM}$ of DM had no measurable (significant) increase in $\tau_{o}$ ([Figure 7D](#f7){ref-type="fig"}). DM at $30\text{ \ nM}$ dramatically increased the open probability ($P_{o}$) of RyR1 channel to $36.2 \pm 12.7$ folds of control ($p < 0.01$) ([Figure 7D](#f7){ref-type="fig"}).

![Influence of nanomolar DM on the gating kinetics of RyR1 channels. (A--C) Representative traces of RyR1 activity in single-channel level in the (A) absence, and (B) presence of $10\text{ \ nM}$ and (C) $30\text{ \ nM}$, respectively. (D) Analysis of the gating parameters of mean closed time ($\tau_{c}$) (top), mean open time ($\tau_{o}$) (middle), and open probability ($P_{o}$) (bottom). Each data point represents the $\text{mean} \pm \text{standard\ error\ of\ the\ mean\  }\left( \text{SEM} \right)$ from three independent channels. Statistical significance between groups was calculated by one-way analysis of variance (ANOVA) followed by post hoc Bonferroni comparison. Note: C, closed state of the channel; DM, deltamethrin; O, open state of the RyR1 channel; $P_{o}$, open probability; RyRs, ryanodine receptors; $\tau_{o}$, mean open time; $\tau_{c}$, mean closed time. \*\*$p < 0.01$, DM vs. control.](ehp-127-067003-g0007){#f7}

Susceptibility to Deltamethrin between Wild-Type and ${RyR}1^{T4826I/T4826I}$ Neurons {#s3.6}
-------------------------------------------------------------------------------------

Given that DM suppressed SCO frequency and amplitude at 6 DIV neurons with $\text{IC}_{50}$ values of $139.6\text{ \ nM}$ and $37.6\text{ \ nM}$, respectively, we selected an intermediate concentration of DM ($100\text{ \ nM}$) to investigate the possible influence of DM on SCOs on the neurons cultured from mice expressing an RyR1 gain-of-function knock-in mutation ($\text{RyR}1^{T4826I/T4826I}$). The SCO frequency in neurons expressing $\text{RyR}1^{T4826I/T4826I}$ was comparable with that measured in neurons cultured from C57BL/6J (WT) mouse pups ([Figure 8A,B](#f8){ref-type="fig"}). However, the SCO amplitude in $\text{RyR}1^{T4826I/T4826I}$ neurons was significantly smaller ($10.7 \pm 4.9\%$; $p < 0.05$) than that measured in WT neurons ([Figure 8A,B](#f8){ref-type="fig"}). $\text{RyR}1^{T4826I/T4826I}$ neurons exhibited a greater SCO response to DM exposure. DM ($100\text{ \ nM}$) treatment inhibited SCO frequency by $58.9 \pm 11.9\%$ in $\text{RyR}1^{T4826I/T4826I}$ cortical neurons, whereas in WT cortical neurons, the inhibition was $11.0 \pm 14.4\%$ ($p < 0.01$) ([Figure 8D](#f8){ref-type="fig"}). Similarly, inhibition of SCO amplitude was greater in $\text{RyR}1^{T4826I/T4826I}$ cortical neurons ($73.2 \pm 5.4\%$) compared with that in WT neurons ($61.0 \pm 2.1\%$) ($p < 0.05$) ([Figure 8D](#f8){ref-type="fig"}).

![Impacts of $\text{RyR}1^{T4826I/T4826I}$ mutation on DM-induced SCO alternation. (A) Representative traces of SCOs in cortical neuronal cultures from WT mice (top trace) and mice carrying $\text{RyR}1^{T4826I/T4826I}$ gain-of-function mutation (bottom trace) recorded at 7 DIV. (B) Quantification of the SCO frequency and amplitude in WT and $\text{RyR}1^{T4828I/T4826I}$ neurons. (C) Representative SCO traces in the absence and presence of DM ($100\text{ \ nM}$) in WT (upper two traces) and $\text{RyR}1^{T4828I/T4826I}$ neurons (lower two traces). Arrowhead indicates the addition of Veh (0.1% DMSO) or DM ($100\text{ \ nM}$). The data from dashed line window were used to analyze the inhibitions. (D) Quantification of DM inhibitions on the SCO frequency and amplitude in WT and $\text{RyR}1^{T4828I/T4826I}$ neurons. DM-induced response (% inhibition) was analyzed by normalizing to respective vehicle control (0.1% DMSO) of each genotype. The mean values of SCO frequency and amplitude of each plate were used as analysis unit. Each data points represents the $\text{mean} \pm \text{standard\ error\ of\ the\ mean\  }\left( \text{SEM} \right)$ from four independent sister cultures. A *t*-test was used to compare the statistical significance of SCO frequency and amplitude between WT and $\text{RyR}1^{T4826I/T4826I}$ neurons as well as the SCO response of DM between two genotypes. Note: DM, deltamethrin; DMSO, dimethylsulfoxide; RyRs, ryanodine receptors; SCO, synchronous ${Ca}^{2 +}$ oscillations; Veh, vehicle; WT, wild type. \*$p < 0.05$; \*\*$p < 0.01$, WT neurons vs. $\text{RyR}1^{T4828I/T4826I}$ neurons.](ehp-127-067003-g0008){#f8}

Effects of ${RyR}1^{T4826I/T4826I}$ Mutation on Deltamethrin-Induced Axon Growth {#s3.7}
--------------------------------------------------------------------------------

The possible influence of $\text{RyR}1^{T4826I/T4826I}$ on axon growth and susceptibility to DM exposure was further investigated using the cortical neuronal culture model. Axonal length in $\text{RyR}1^{T4826I/T4826I}$ neurons was significantly longer ($203.3 \pm 6.2\;\mu m$) than that in WT neurons ($159.7 \pm 4.7\;\mu m$; $p < 0.01$) at 2 DIV ([Figure 9A,B](#f9){ref-type="fig"}). $\text{RyR}1^{T4826I/T4826I}$ cortical neurons treated with DM at $100\text{ \ nM}$ had significantly ($p < 0.01$) longer mean axon length ([Figure 9A,B](#f9){ref-type="fig"}). $\text{RyR}1^{T4826I/T4826I}$ neurons treated with DM (30 and $100\text{ \ nM}$) exposure also displayed longer axon length compared with that in WT neurons with respective DM treatment ($p < 0.01$ and $p < 0.05$, respectively) ([Figure 9A,B](#f9){ref-type="fig"}).

![Impacts of $\text{RyR}1^{T4826I/T4826I}$ mutation on DM-induced axonal outgrowth. (A) Representative images of WT and $\text{RyR}1^{T4826I/T4826I}$ mutation neurons exposed to Veh (0.1% DMSO) and DM ($30\text{ \ nM}$ and $100\text{ \ nM}$) commencing 3 h after plating and immunostained with MAP-2B antibody at 2 DIV. (B) Quantification of the axon length after DM exposure in WT and $\text{RyR}1^{T4826I/T4826I}$ mutation neurons. The total number of neurons tested was inserted in the bar graph, and axonal length of each neuron was used as analysis unit. Each data point represents the $\text{mean} \pm \text{standard\ error\ of\ the\ mean\  }\left( \text{SEM} \right)$ from two independent sister cultures, each with three wells. Statistical significance between WT and $\text{RyR}1^{T4826I/T4826I}$ neurons was performed using two-way analysis of variance (ANOVA) followed by post hoc Bonferroni comparison. Note: DM, deltamethrin; DMSO, dimethylsulfoxide; RyRs, ryanodine receptors; Veh, vehicle; WT, wild type. \*$p < 0.05$; \*\*$p < 0.01$, DM vs. Veh; ^\#^$p < 0.05$; ^\#\#^$p < 0.01$, $\text{RyR}1^{T4826I/T4826I}$ vs. WT at same treatment condition. $\text{Bar} = 50\;\mu m$.](ehp-127-067003-g0009){#f9}

Discussion {#s4}
==========

Primary cultured cortical neurons recapitulate several neurodevelopmental and functional hallmarks of neurodevelopment observed *in vivo* ([@c27]; [@c87]). This culture system displays a variety of intrinsic signaling pathways that are essential to the development and consolidation of the neuronal network ([@c36]). During development, dendritic arborization, axonal elongation, and synapse formation form an extensive neuronal network ([@c36]), displaying spontaneous ESA ([@c33]) and SCOs ([@c10]; [@c9]), two interrelated and essential biological processes that affect neuronal network refinement ([@c27]; [@c71]). Primary cultured cortical neurons have been widely used to study neuronal function *in vitro* and to explore the molecular mechanism of neurite outgrowth in the developing central nervous system ([@c48]; [@c67]) as well as to investigate the developmental neurotoxicity and mechanisms of action of drug candidates and environmental toxicants ([@c8], [@c9]; [@c36]). In this study, we demonstrated that as cortical neuronal networks developed *in vitro*, SCO frequency and ESA increased in concert with morphometric complexity. The temporal increase in morphological complexity coincides with enhanced functional connectivity across the neuronal network that likely mimic many aspects of the developing brain ([@c27]; [@c87]). Importantly, nanomolar DM was shown to be capable of altering both morphometric and functional parameters.

Pyrethroids metabolites have been detected in urine, breast milk, and blood samples ([@c59]; [@c65]; [@c72]; [@c99]). Recent epidemiological evidence indicates that environmental exposures to pyrethroid are associated with increased risks of delayed neuronal development ([@c39]; [@c80]; [@c101]). Previous results from animal models also indicated that perinatal exposure *in vivo* to low doses of pyrethroid altered the function of central nervous system later in life. For example, prenatal exposure of mice to low doses ($0.3\;{mg}/{kg}$ and $1\;{mg}/{kg}$ every 3 d) of DM resulted in ADHD-like behavior, which was presumably mediated via altered dopaminergic signaling pathways ([@c72]). The concentration of DM in brain tissue could reach $\sim 16\text{ \ ng}/g$ ($30\text{ \ nM}$) after a single oral dose of $0.5\;{mg}/{kg}$ DM in postnatal day 15 and 21 rats ([@c61]). In addition, postnatal exposure to a low dose of cypermethrin ($1.5\;{mg}/{kg}$) enhanced the susceptibility of rats to dopaminergic neurodegeneration if rechallenged during adulthood ([@c82]). Consistent with these findings, prenatal mice receiving low doses ($5\;{mg}/{kg}$) of cypermethrin exposure were recently shown to develop abnormal social and adaptive responses that were correlated with changes in brain transcriptional profiles ([@c54]). Additional evidence from zebrafish also indicated the potential of both Type I and Type II pyrethroids to affect neuronal developmental ([@c4]; [@c32]; [@c40]; [@c47]; [@c100]). Here we demonstrated that cortical neurons exposed subchronically to DM ($< 1\;\mu M$) for 6 d displayed concentration-dependent decreases in SCO frequency. Similarly, cortical neurons receiving subchronic DM (10 and $30\text{ \ nM}$) exposure for 4 d after plating displayed concentration-dependent inhibition of electrical spike frequency and burst frequency. To our knowledge, these results provide the first evidence that nanomolar concentrations of DM that are relevant to environmental exposures ([@c59]; [@c65]; [@c72]; [@c99]) were capable of altering neuronal network activity *in vitro*.

Suppression of electric discharges by DM seemed to wane with longer exposures to (7 vs. 10 vs. 13 d), despite the continuous presence of this pyrethroid. The inhibition of SCO frequency at 6 DIV was slightly more effective than at 8 DIV; however, the level of suppression achieved continued to wane as the neurons developed *in vitro* further. Similarly, although DM displayed similar potency on suppression of SCO amplitude throughout the development stages investigated here, its inhibitory efficacy on SCO amplitude was greater when introduced at earlier stages of development, and this response waned gradually in the neuronal network at more advanced stages of development *in vitro*. Collectively, based on *in vitro* studies, these data suggest that cortical neuronal networks were more sensitive to DM when exposed at early stages of development. There is mounting evidence that pyrethroid neurotoxicity is age dependent and that there are critical windows of susceptibility ([@c77]). Neonatal rats were shown to be 16-fold more susceptible than adults to the acute toxicity of DM ([@c79]). Similarly, cypermethrin and permethrin were reported to be 17- and sixfold more toxic to neonatal day 8 rats compared with adults ([@c7]). The age sensitivity difference can be partially explained by the lower metabolic detoxifying capabilities in rats during the neonatal period ([@c79]), consistent with recent toxicokinetic data in which the brain concentration of DM at postnatal day 15 was only $\sim \text{twofold}$ of that on adult rats ([@c61]). Evidence for age-dependent susceptibility to pyrethroids was also indicated by subchronic and chronic exposure studies in rodent and zebrafish models. Prenatal mice receiving low doses ($5\;{mg}/{kg}$) of cypermethrin exposure developed abnormal motor activity and social and adaptive responses ([@c54]), while adults were much less sensitive ([@c82]). In zebrafish embryos and juveniles, bifenthrin exposure produced opposite effect on dopamine metabolism ([@c4]).

Activity-dependent calcium signaling has been shown to regulate dendritic growth and branching ([@c51]). An optimal window for $\left\lbrack {Ca}^{2 +} \right\rbrack_{i}$ is required for activity-dependent neurite extension and branching. Small to moderate amplification of ${Ca}^{2 +}$ signaling stimulates dendritic growth, whereas excessive ${Ca}^{2 +}$ alteration may stall dendritic growth ([@c38]; [@c43]). Our data demonstrated that DM-modulated ${Ca}^{2 +}$ signaling was sufficient to alter axonal growth and neuronal complexity. DM exposure produced nonmonotonic response on the stimulation of axonal growth and neuronal complexity, with peak response occurring at 100 and $300\text{ \ nM}$, respectively. The concentration-dependent profiles of DM-stimulated axon growth and neuron complexity were therefore consistent with activity-dependent dendritic growth ([@c38]; [@c43]). It was reported that DM at $1\;\mu M$ increased neurite outgrowth in rat cortical neurons through endogenous BDNF/tropomyosin receptor kinase B pathways ([@c46]). However, in the current study, we demonstrated that DM ($1\;\mu M$) affected neither axon growth nor dendritic branching. One of the main factors that may contribute to this discrepancy could be the use of neurons at different stages of development, especially considering the distinct susceptibility to DM exposure in distinct developmental stages discussed above. Another factor that may also contribute to the discrepancy could be the exposure duration. We treated neurons for 48 h and 6 d commencing 3 h after plating for axon growth and dendritic complexity measurements, respectively, while in the previous study, neurons were exposed at 7 DIV for 3, 6, 12, and 24 h, respectively ([@c46]).

RyRs are ${Ca}^{2 +}$ channels that regulate ${Ca}^{2 +}$ release from the sarco/endoplasmic reticulum ([@c68]). All three subtypes of RyRs were reported to be expressed in the central nervous system ([@c28]; [@c34]; [@c37]; [@c52]; [@c58]). We demonstrated that alteration of RyR1 function was sufficient to affect functional outcomes of *in vitro* neuronal networks. Primary cultured cortical neuronal network from the mouse pups carrying $\text{RyR}1^{T4826I/T4826I}$ gain-of-function mutation exhibited significantly lower SCO amplitude and much longer axons. This was consistent with the demonstration that RyRs were responsible for producing temporally and spatially defined ${Ca}^{2 +}$ signals important for neuronal growth and plasticity ([@c64]; [@c93]; [@c96]). DM has been reported to alter a variety of channel functions ([@c20]; [@c84]). Using Golgi staining of brain section, Keil and coworkers ([@c50]) recently reported that CA1 hippocampal pyramidal neurons of young male $\text{RyR}1^{T4826I/T4826I}$ mice exhibit significantly increased dendritic arborization compared with WT, whereas genotype differences could be detected within the somatosensory cortex of both sexes. Importantly, such morphometric changes in complexity were correlated with behavioral performance in the three-chambered social approach test ([@c50]).

We demonstrated that DM altered RyR1 gating kinetics at levels as low as $10\text{ \ nM}$, providing the evidence that RyR1 was a direct sensitive target of DM. It should be mentioned that $> 3\;\mu M$ DM was required to elicit changes in specific $$ binding to RyR1, RyR2, and a mixture of three types of RyRs prepared from cortex. This apparent discrepancy may be due to an underestimate of the true potency because of the high lipid content in the microsomal preparations used in these assays and the high lipophilicity of DM. This phenomenon was also observed for lipophilic polychlorinated biphenyls (PCBs), such as PCB-202 and PCB-95 ([@c42]; [@c76]; [@c93], [@c95]). Additional evidence of involvement of RyR1 as a molecular target of DM-induced changes in functional neuronal network came from the results of experiments with neural networks expressing the gain-of-function mutation $\text{RyR}1^{T4826I/T4826I}$, which showed additional effect in response to DM exposure. Likewise, we could not rule out other potential molecular targets such as ${Ca}_{v}2.2$ that were reported to be highly sensitive to DM exposure ([@c19]; [@c88]). We previously demonstrated that bifenthrin altered the SCO patterns at nanomolar concentrations, apparently without direct effect on the gating kinetics of RyR1 ([@c9]). More recently, however, exposure of zebrafish to bifenthrin 1, 3, and 5 d postfertilization was shown to alter transcriptional regulation of RyRs and elements in the mechanistic target of rapamycin (mTOR) signaling pathway ([@c32]). Therefore, it appears that RyRs may be involved either directly or indirectly in neurotoxicity of both Type I (bifenthrin) and Type II (DM) pyrethroids.

In summary, we demonstrated that DM at nanomolar concentrations altered the cortical neuronal network excitability, axonal growth, and dendritic arborization of neuronal cells *in vitro*. We also identified that neuronal networks exposed early in their *in vitro* developmental stages were more sensitive to low nanomolar DM exposure than later stages, consistent with recent reports from *in vivo* vertebrate models of exposure. Importantly, we provided direct evidence that low nanomolar DM directly engaged RyR and altered channel function, identifying a highly sensitive target that may be generalizable to other Type II pyrethroids.
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